A generally applicable translational strategy identifies S100A4 as a candidate gene in allergy

Science Translational Medicine

Volumn 6, Issue 218, 2014, Pages

  Bruhn, Sören ^a   Fang, Yu ^b,c   Barrenäs, Fredrik ^a   Gustafsson, Mika ^a   Zhang, Huan ^a   Konstantinell, Aelita ^a   Krönke, Andrea ^d   Sönnichsen, Birte ^d   Bresnick, Anne ^e   Dulyaninova, Natalya ^e   Wang, Hui ^a   Zhao, Yelin ^a   Klingelhöfer, Jörg ^f   Ambartsumian, Noona ^f   Beck, Mette K ^g   Nestor, Colm ^a   Bona, Elsa ^h   Xiang, Zou ^c   Benson, Mikael ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d Cenix BioScience GmbH   (Germany)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^h BORÅS HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALVASCULIN; CALVASCULIN ANTIBODY; INTERLEUKIN 13; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; EFFECTOR CELL; GENE DELETION; GENE EXPRESSION; HAY FEVER; HUMAN; HUMAN CELL; HUMAN TISSUE; IL13 GENE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; S100A4 GENE; SKIN ALLERGY; T LYMPHOCYTE ACTIVATION; TH2 CELL;

ADULT; ANIMALS; ANTIBODIES, BLOCKING; CELL POLARITY; DENDRITIC CELLS; DERMATITIS; DISEASE MODELS, ANIMAL; EPITOPES; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; HUMANS; HYPERSENSITIVITY; IMMUNOLOGIC MEMORY; INTERLEUKIN-13; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MODELS, IMMUNOLOGICAL; RHINITIS, ALLERGIC, SEASONAL; S100 PROTEINS; TH2 CELLS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84892540269     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3007410     Document Type: Article

References (66)

1. E. Petretto, E. T. Liu, T. J. Aitman, A gene harvest revealing the archeology and complexity of human disease. Nat. Genet. 39, 1299-1301 (2007).
2. E. Segal, N. Friedman, N. Kaminski, A. Regev, D. Koller, From signatures to models: Understanding cancer using microarrays. Nat. Genet. 37, S38-S45 (2005).
3. V. K. Mootha, C. M. Lindgren, K. F. Eriksson, A. Subramanian, S. Sihag, J. Lehar, P. Puigserver, E. Carlsson, M. Ridderstråle, E. Laurila, N. Houstis, M. J. Daly, N. Patterson, J. P. Mesirov, T. R. Golub, P. Tamayo, B. Spiegelman, E. S. Lander, J. N. Hirschhorn, D. Altshuler, L. C. Groop, PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273 (2003).
4. J. Lamb, S. Ramaswamy, H. L. Ford, B. Contreras, R. V. Martinez, F. S. Kittrell, C. A. Zahnow, N. Patterson, T. R. Golub, M. E. Ewen, A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114, 323-334 (2003).
5. E. Huang, S. Ishida, J. Pittman, H. Dressman, A. Bild, M. Kloos, M. D'Amico, R. G. Pestell, M. West, J. R. Nevins, Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat. Genet. 34, 226-230 (2003).
6. M. A. Pujana, J. D. Han, L. M. Starita, K. N. Stevens, M. Tewari, J. S. Ahn, G. Rennert, V. Moreno, T. Kirchhoff, B. Gold, V. Assmann, W. M. Elshamy, J. F. Rual, D. Levine, L. S. Rozek, R. S. Gelman, K. C. Gunsalus, R. A. Greenberg, B. Sobhian, N. Bertin, K. Venkatesan, N. Ayivi-Guedehoussou, X. Solé, P. Hernández, C. Lázaro, K. L. Nathanson, B. L. Weber, M. E. Cusick, D. E. Hill, K. Offit, D. M. Livingston, S. B. Gruber, J. D. Parvin, M. Vidal, Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat. Genet. 39, 1338-1349 (2007).
7. + T cell transcription signature predicts prognosis in autoimmune disease. Nat. Med. 16, 586-591 (2010).
8. + cells from patients with intermittent allergic rhinitis. Allergy 67, 33-40 (2012).
9. M. Benson, L. Carlsson, G. Guillot, M. Jernås, M. A. Langston, M. Rudemo, B. Andersson, A network-based analysis of allergen-challenged CD4+ T cells from patients with allergic rhinitis. Genes Immun. 7, 514-521 (2006).
10. H. Wang, F. Barrenäs, S. Bruhn, R. Mobini, M. Benson, Increased IFN-γ activity in seasonal allergic rhinitis is decreased by corticosteroid treatment. J. Allergy Clin. Immunol. 124, 1360-1362 (2009).
11. M. Benson, M. A. Langston, M. Adner, B. Andersson, A. Torinssson-Naluai, L. O. Cardell, A network-based analysis of the late-phase reaction of the skin. J. Allergy Clin. Immunol. 118, 220-225 (2006).
12. F. Barrenäs, S. Chavali, A. C. Alves, L. Coin, M. R. Jarvelin, R. Jörnsten, M. A. Langston, A. Ramasamy, G. Rogers, H. Wang, M. Benson, Highly interconnected genes in disease-specific networks are enriched for disease-associated polymorphisms. Genome Biol. 13, R46 (2012).
13. M. Wills-Karp, IL-12/IL-13 axis in allergic asthma. J. Allergy Clin. Immunol. 107, 9-18 (2001).
14. T. Ideker, R. Sharan, Protein networks in disease. Genome Res. 18, 644-652 (2008).
15. I. Amit, A. Regev, N. Hacohen, Strategies to discover regulatory circuits of the mammalian immune system. Nat. Rev. Immunol. 11, 873-880 (2011).
16. T. Ideker, N. J. Krogan, Differential network biology. Mol. Syst. Biol. 8, 565 (2012).
17. M. Vidal, M. E. Cusick, A. L. Barabási, Interactome networks and human disease. Cell 144, 986-998 (2011).
18. C. Brightling, S. Saha, F. Hollins, Interleukin-13: Prospects for new treatments. Clin. Exp. Allergy 40, 42-49 (2010).
19. R. Tachdjian, S. Al Khatib, A. Schwinglshackl, H. S. Kim, A. Chen, J. Blasioli, C. Mathias, H. Y. Kim, D. T. Umetsu, H. C. Oettgen, T. A. Chatila, In vivo regulation of the allergic response by the IL-4 receptor α chain immunoreceptor tyrosine-based inhibitory motif. J. Allergy Clin. Immunol. 125, 1128-1136.e8 (2010).
20. A. E. Kelly-Welch, E. M. Hanson, M. R. Boothby, A. D. Keegan, Interleukin-4 and interleukin-13 signaling connections maps. Science 300, 1527-1528 (2003).
21. M. Wills-Karp, Interleukin-13 in asthma pathogenesis. Immunol. Rev. 202, 175-190 (2004).
22. I. M. Adcock, G. Caramori, K. F. Chung, New targets for drug development in asthma. Lancet 372, 1073-1087 (2008).
23. J. Corren, R. F. Lemanske Jr., N. A. Hanania, P. E. Korenblat, M. V. Parsey, J. R. Arron, J. M. Harris, H. Scheerens, L. C. Wu, Z. Su, Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 365, 1088-1098 (2011).
24. S. Bruhn, M. Katzenellenbogen, M. Gustafsson, A. Krönke, B. Sönnichsen, H. Zhang, M. Benson, Combining gene expression microarray- and cluster analysis with sequence-based predictions to identify regulators of IL-13 in allergy. Cytokine 60, 736-740 (2012).
25. A. Masuda, Y. Yoshikai, H. Kume, T. Matsuguchi, The interaction between GATA proteins and activator protein-1 promotes the transcription of IL-13 in mast cells. J. Immunol. 173, 5564-5573 (2004).
26. A. Lorentz, I. Klopp, T. Gebhardt, M. P. Manns, S. C. Bischoff, Role of activator protein 1, nuclear factor-κB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells. J. Allergy Clin. Immunol. 111, 1062-1068 (2003).
27. + T cells. J. Immunol. 170, 3109-3117 (2003).
28. W. Zheng, R. A. Flavell, The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587-596 (1997).
29. B. R. Cullen, Enhancing and confirming the specificity of RNAi experiments. Nat. Methods 3, 677-681 (2006).
30. Z. H. Li, N. G. Dulyaninova, R. P. House, S. C. Almo, A. R. Bresnick, S100A4 regulates macrophage chemotaxis. Mol. Biol. Cell 21, 2598-2610 (2010).
31. M. Boguniewicz, D. Y. M. Leung, Atopic dermatitis: A disease of altered skin barrier and immune dysregulation. Immunol. Rev. 242, 233-246 (2011).
32. E. B. Lindblad, Aluminium adjuvants - In retrospect and prospect. Vaccine 22, 3658-3668 (2004).
33. F. D. Finkelman, J. Holmes, I. M. Katona, J. F. Urban Jr., M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, W. E. Paul, Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8, 303-333 (1990).
34. R. Coffman, H. Savelkoul, D. Lebman, Cytokine regulation of immunoglobulin isotype switching and expression. Semin. Immunol. 1, 55-63 (1989).
35. K. Oboki, T. Ohno, H. Saito, S. Nakae, Th17 and allergy. Allergol. Int. 57, 121-134 (2008).
36. A. D. Christensen, C. Haase, Immunological mechanisms of contact hypersensitivity in mice. APMIS 120, 1-27 (2012).
37. H. Ge, Z. Liu, G. M. Church, M. Vidal, Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae. Nat. Genet. 29, 482- 486 (2001).
38. P. Minguez, J. Dopazo, Assessing the biological significance of gene expression signatures and co-expression modules by studying their network properties. PLOS One 6, e17474 (2011).
39. M. Narayanan, A. Vetta, E. E. Schadt, J. Zhu, Simultaneous clustering of multiple gene expression and physical interaction datasets. PLOS Comput. Biol. 6, e1000742 (2010).
40. A. K. Ramani, Z. Li, G. T. Hart, M. W. Carlson, D. R. Boutz, E. M. Marcotte, A map of human protein interactions derived from co-expression of human mRNAs and their orthologs. Mol. Syst. Biol. 4, 180 (2008).
41. J. Chen, H. Liang, A. Fernández, Protein structure protection commits gene expression patterns. Genome Biol. 9, R107 (2008).
42. C. Zhang, A. Browne, D. Child, J. R. Divito, J. A. Stevenson, R. E. Tanzi, Loss of function of ATXN1 increases amyloid b-protein levels by potentiating b-secretase processing of β-amyloid precursor protein. J. Biol. Chem. 285, 8515-8526 (2010).
43. F. Colland, X. Jacq, V. Trouplin, C. Mougin, C. Groizeleau, A. Hamburger, A. Meil, J. Wojcik, P. Legrain, J. M. Gauthier, Functional proteomics mapping of a human signaling pathway. Genome Res. 14, 1324-1332 (2004).
44. W. Wu, E. Hodges, C. Höög, Thorough validation of siRNA-induced cell death phenotypes defines new anti-apoptotic protein. Nucleic Acids Res. 34, e13 (2006).
45. R. Donato, S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637-668 (2001).
46. R. Donato, B. R. Cannon, G. Sorci, F. Riuzzi, K. Hsu, D. J. Weber, C. L. Geczy, Functions of S100 proteins. Curr. Mol. Med. 13, 24-57 (2013).
47. L. Oslejsková, M. Grigorian, S. Gay, M. Neidhart, L. Senolt, The metastasis associated protein S100A4: A potential novel link to inflammation and consequent aggressive behaviour of rheumatoid arthritis synovial fibroblasts. Ann. Rheum. Dis. 67, 1499-1504 (2008).
48. D. B. Zimmer, J. Chaplin, A. Baldwin, M. Rast, S100-mediated signal transduction in the nervous system and neurological diseases. Cell Mol. Biol. 51, 201-214 (2005).
49. S. K. Mishra, H. R. Siddique, M. Saleem, S100A4 calcium-binding protein is key player in tumor progression and metastasis: Preclinical and clinical evidence. Cancer Metastasis Rev. 31, 163-172 (2012).
50. H2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-γ, IL-1β, TNF-α, or neutrophils. J. Allergy Clin. Immunol. 106, 307-312 (2000).
51. L. Bian, P. Strzyz, I. M. Jonsson, M. Erlandsson, A. Hellvard, M. Brisslert, C. Ohlsson, N. Ambartsumian, M. Grigorian, M. Bokarewa, S100A4 deficiency is associated with efficient bacterial clearance and protects against joint destruction during Staphylococcal infection. J. Infect. Dis. 204, 722-730 (2011).
52. C. H. Österreicher, M. Penz-Österreicher, S. I. Grivennikov, M. Guma, E. K. Koltsova, C. Datz, R. Sasik, G. Hardiman, M. Karin, D. A. Brenner, Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proc. Natl. Acad. Sci. U.S.A. 108, 308-313 (2011).
53. J. Bousquet, C. Bachert, G. W. Canonica, T. B. Casale, A. A. Cruz, R. J. Lockey, T. Zuberbier; Extended Global Allergy and Asthma European Network, World Allergy Organization and Allergic Rhinitis and its Impact on Asthma Study Group, Unmet needs in severe chronic upper airway disease (SCUAD). J. Allergy Clin. Immunol. 124, 428-433 (2009).
54. V. N. Malashkevich, N. G. Dulyaninova, U. A. Ramagopal, M. A. Liriano, K. M. Varney, D. Knight, M. Brenowitz, D. J. Weber, S. C. Almo, A. R. Bresnick, Phenothiazines inhibit S100A4 function by inducing protein oligomerization. Proc. Natl. Acad. Sci. U.S.A. 107, 8605-8610 (2010).
55. S. C. Garrett, L. Hodgson, A. Rybin, A. Toutchkine, K. M. Hahn, D. S. Lawrence, A. R. Bresnick, A biosensor of S100A4 metastasis factor activation: Inhibitor screening and cellular activation dynamics. Biochemistry 47, 986-996 (2008).
56. N. G. Dulyaninova, K. M. Hite, W. D. Zencheck, D. A. Scudiero, S. C. Almo, R. H. Shoemaker, A. R. Bresnick, Cysteine 81 is critical for the interaction of S100A4 and myosin-IIA. Biochemistry 50, 7218-7227 (2011).
57. J. Klingelhöfer, B. Grum-Schwensen, M. K. Beck, R. S. Knudsen, M. Grigorian, E. Lukanidin, N. Ambartsumian, Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion. Neoplasia 14, 1260-1268 (2012).
58. S. Chavali, S. Bruhn, K. Tiemann, P. Sætrom, F. Barrenäs, T. Saito, K. Kanduri, H. Wang, M. Benson, MicroRNAs act complementarily to regulate disease-related mRNA modules in human diseases. RNA 19, 1552-1562 (2013).
59. H. Wang, J. Gottfries, F. Barrenäs, M. Benson, Identification of novel biomarkers in seasonal allergic rhinitis by combining proteomic, multivariate and pathway analysis. PLOS One 6, e23563 (2011).
60. H. Williams, P. Jburney, R. Hay, C. Archer, M. Shipley, J. Ahunter, E. Bingham, A. Finlay, A. Pembroke, R. C. Graham-Brown, D. A. Atherton, M. S. Lewis-Jones, C. A. Holden, J. I. Harper, R. H. Champion, T. F. Poyner, J. Launer, T. J. David, The U. K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br. J. Dermatol. 131, 383- 396 (1994).
61. F. Rahimi, K. Hsu, Y. Endoh, C. L. Geczy, FGF-2, IL-1β and TGF-β regulate fibroblast expression of S100A8. FEBS J. 272, 2811-2827 (2005).
62. D. Szklarczyk, A. Franceschini, M. Kuhn, M. Simonovic, A. Roth, P. Minguez, T. Doerks, M. Stark, J. Muller, P. Bork, L. J. Jensen, C. von Mering, The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39, D561-D568 (2011).
63. F. Schwenk, U. Baron, K. Rajewsky, A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080-5081 (1995).
64. S. Abdali, B. De Laere, M. Poulsen, M. Grigorian, E. Lukanidin, J. R. Klingelhöfer, Toward methodology for detection of cancer-promoting S100A4 protein conformations in sub-nanomolar concentrations using Raman and SERS. J. Phys. Chem. C 114, 7274-7279 (2010).
65. H2-specific noncoding RNA GATA3-AS1. J. Allergy Clin. Immunol. 132, 1005-1008 (2013).
66. B. Sönnichsen, L. Koski, A. Walsh, P. Marschall, B. Neumann, M. Brehm, A. M. Alleaume, J. Artelt, P. Bettencourt, E. Cassin, M. Hewitson, C. Holz, M. Khan, S. Lazik, C. Martin, B. Nitzsche, M. Ruer, J. Stamford, M. Winzi, R. Heinkel, M. Röder, J. Finell, H. Häntsch, S. J. Jones, M. Jones, F. Piano, K. C. Gunsalus, K. Oegema, P. Gönczy, A. Coulson, A. A. Hyman, C. J. Echeverri, Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans. Nature 434, 462-469 (2005).